Corneal Confocal Microscopy is Superior to Skin Biopsy as a Surrogate Marker of Human Diabetic Neuropathy

Aim and Method: There is an urgent need to develop surrogate markers to aid in the diagnosis and assessment of treatment efficacy in human diabetic neuropathy. 22 diabetic patients underwent detailed assessment of Neuropathy Impairment Score in the lower limbs (NIS-LL), electrophysiology (EMG), quan...

Full description

Bibliographic Details
Main Authors: C Quattrini, M Tavakoli, P Kallinikos, A Boulton, N Efron, R Malik
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2005-10-01
Series:Iranian Journal of Public Health
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/2437.pdf&manuscript_id=2437
_version_ 1819175351879729152
author C Quattrini
M Tavakoli
P Kallinikos
A Boulton
N Efron
R Malik
author_facet C Quattrini
M Tavakoli
P Kallinikos
A Boulton
N Efron
R Malik
author_sort C Quattrini
collection DOAJ
description Aim and Method: There is an urgent need to develop surrogate markers to aid in the diagnosis and assessment of treatment efficacy in human diabetic neuropathy. 22 diabetic patients underwent detailed assessment of Neuropathy Impairment Score in the lower limbs (NIS-LL), electrophysiology (EMG), quantitative sensory testing (QST), corneal confocal microscopy (CCFM) and skin biopsy. On the basis of NIS-LL, EMG and QST assessment 11 patients were classed to have no neuropathy (age= 5010 years, NIS-LL= 4+/-4, Peroneal Nerve Conduction Velocity (PNCV) 50+/- 10 m/s, Sural Nerve Amplitude Potential (SNAP) 11 +/- 7 mA, Tibial Nerve Onset Latency (TNOL) 15+/-2 ms, Vibration Perception Threshold (VPT) 7+/- 4 V, Cooling Detection Threshold (CDT) 57 +/- 28 pc, Deep Breathing Heart Rate Variability (DBHRV) 67+/-28 pc, and 11 had neuropathy (age 5311 years, NIS-LL=17+/-12, PNCV 39+/- 8 m/s, SNAP 5+/- 3 mA, TNOL 18+/-2 ms, VPT 30+/- 13 Volts, CDT 97+/- 2 pc, DBHRV 13+/-29 pc. CCFM was performed to quantify corneal nerve morphology: nerve fibre density (NFD), tortuosity (NFT), and branch density (NFBD) were compared with normative values from healthy volunteers (n=23, age 5215). 3 mm punch skin biopsies were performed from the dorsum of the foot and immunohistochemical staining was performed with PGP 9.5 to quantify dermal nerve fibre density (DNFD) and compared with normative values from 22 volunteers (age and sex matched). Results: 1) CCFM demonstrated differences between non neuropathic diabetic, neuropathic diabetic and control groups. Respective results are given as mean +/- SD: NFD 29+/-10, 35+/-13, and 46+/-16 nerves/mm2 (ANOVA P= 0.02), NFT 8+/-8, 19+/-14, 24+/-10 (tortuosity index, ANOVA P=0.002), NFBD 6+/-2, 6+/-3, 33+/-26 branches/mm2 (ANOVA P< 0.001). Post-hoc analysis showed a significant difference between both diabetic groups and controls for NFBD (P< 0.01), but only for non neuropathic diabetic groups compared to controls for NFD (P< 0.05), NFT (P< 0.01). 2) DNFD was reduced in all diabetic patients, non neuropathic and neuropathic, compared to controls (respectively 203+/-114, 190+/-58, and 414+/-196 fibres/mm2: mean + SD, ANOVA P< 0.001). No differences between the two patient groups were showed by post-hoc analysis. 3) Positive correlations were found between NFBD and SNAP (Pearson r= 0.55, P= 0.01), NFT and SNAP (r= 0.55, P= 0.004), and DNFD and SNAP (r=0.53, P= 0.01). NFD and NFBD inversely correlated with Peroneal F waves Latencies at (r=-0.63, P= 0.002) and r=-0.64, P= 0.001, respectively. Conclusions: Whilst both CCFM and DNFD were more reduced in diabetic patients with compared to those without neuropathy this did not reach significance. Corneal nerve morphology and skin DNFD correlated with electrophysiological parameters. However, they did not correlate to each other. This preliminary study demonstrates significant associations between corneal nerve morphology, ENFD and conventional measures of neuropathic severity suggesting that they may be reliable surrogate measures of human diabetic neuropathy. The correlation between some of the CCFM parameters and F waves suggests that CCFM may be particularly important in the very early stages of diabetic neuropathy.
first_indexed 2024-12-22T20:53:30Z
format Article
id doaj.art-de440f0b9d02439b812dcff2662898e0
institution Directory Open Access Journal
issn 2251-6085
language English
last_indexed 2024-12-22T20:53:30Z
publishDate 2005-10-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Public Health
spelling doaj.art-de440f0b9d02439b812dcff2662898e02022-12-21T18:13:01ZengTehran University of Medical SciencesIranian Journal of Public Health2251-60852005-10-0134Sup1718Corneal Confocal Microscopy is Superior to Skin Biopsy as a Surrogate Marker of Human Diabetic NeuropathyC QuattriniM TavakoliP KallinikosA BoultonN EfronR MalikAim and Method: There is an urgent need to develop surrogate markers to aid in the diagnosis and assessment of treatment efficacy in human diabetic neuropathy. 22 diabetic patients underwent detailed assessment of Neuropathy Impairment Score in the lower limbs (NIS-LL), electrophysiology (EMG), quantitative sensory testing (QST), corneal confocal microscopy (CCFM) and skin biopsy. On the basis of NIS-LL, EMG and QST assessment 11 patients were classed to have no neuropathy (age= 5010 years, NIS-LL= 4+/-4, Peroneal Nerve Conduction Velocity (PNCV) 50+/- 10 m/s, Sural Nerve Amplitude Potential (SNAP) 11 +/- 7 mA, Tibial Nerve Onset Latency (TNOL) 15+/-2 ms, Vibration Perception Threshold (VPT) 7+/- 4 V, Cooling Detection Threshold (CDT) 57 +/- 28 pc, Deep Breathing Heart Rate Variability (DBHRV) 67+/-28 pc, and 11 had neuropathy (age 5311 years, NIS-LL=17+/-12, PNCV 39+/- 8 m/s, SNAP 5+/- 3 mA, TNOL 18+/-2 ms, VPT 30+/- 13 Volts, CDT 97+/- 2 pc, DBHRV 13+/-29 pc. CCFM was performed to quantify corneal nerve morphology: nerve fibre density (NFD), tortuosity (NFT), and branch density (NFBD) were compared with normative values from healthy volunteers (n=23, age 5215). 3 mm punch skin biopsies were performed from the dorsum of the foot and immunohistochemical staining was performed with PGP 9.5 to quantify dermal nerve fibre density (DNFD) and compared with normative values from 22 volunteers (age and sex matched). Results: 1) CCFM demonstrated differences between non neuropathic diabetic, neuropathic diabetic and control groups. Respective results are given as mean +/- SD: NFD 29+/-10, 35+/-13, and 46+/-16 nerves/mm2 (ANOVA P= 0.02), NFT 8+/-8, 19+/-14, 24+/-10 (tortuosity index, ANOVA P=0.002), NFBD 6+/-2, 6+/-3, 33+/-26 branches/mm2 (ANOVA P< 0.001). Post-hoc analysis showed a significant difference between both diabetic groups and controls for NFBD (P< 0.01), but only for non neuropathic diabetic groups compared to controls for NFD (P< 0.05), NFT (P< 0.01). 2) DNFD was reduced in all diabetic patients, non neuropathic and neuropathic, compared to controls (respectively 203+/-114, 190+/-58, and 414+/-196 fibres/mm2: mean + SD, ANOVA P< 0.001). No differences between the two patient groups were showed by post-hoc analysis. 3) Positive correlations were found between NFBD and SNAP (Pearson r= 0.55, P= 0.01), NFT and SNAP (r= 0.55, P= 0.004), and DNFD and SNAP (r=0.53, P= 0.01). NFD and NFBD inversely correlated with Peroneal F waves Latencies at (r=-0.63, P= 0.002) and r=-0.64, P= 0.001, respectively. Conclusions: Whilst both CCFM and DNFD were more reduced in diabetic patients with compared to those without neuropathy this did not reach significance. Corneal nerve morphology and skin DNFD correlated with electrophysiological parameters. However, they did not correlate to each other. This preliminary study demonstrates significant associations between corneal nerve morphology, ENFD and conventional measures of neuropathic severity suggesting that they may be reliable surrogate measures of human diabetic neuropathy. The correlation between some of the CCFM parameters and F waves suggests that CCFM may be particularly important in the very early stages of diabetic neuropathy.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/2437.pdf&manuscript_id=2437Confocal microscopyCorneal nervesSkin biopsyDiabetic neuropathy
spellingShingle C Quattrini
M Tavakoli
P Kallinikos
A Boulton
N Efron
R Malik
Corneal Confocal Microscopy is Superior to Skin Biopsy as a Surrogate Marker of Human Diabetic Neuropathy
Iranian Journal of Public Health
Confocal microscopy
Corneal nerves
Skin biopsy
Diabetic neuropathy
title Corneal Confocal Microscopy is Superior to Skin Biopsy as a Surrogate Marker of Human Diabetic Neuropathy
title_full Corneal Confocal Microscopy is Superior to Skin Biopsy as a Surrogate Marker of Human Diabetic Neuropathy
title_fullStr Corneal Confocal Microscopy is Superior to Skin Biopsy as a Surrogate Marker of Human Diabetic Neuropathy
title_full_unstemmed Corneal Confocal Microscopy is Superior to Skin Biopsy as a Surrogate Marker of Human Diabetic Neuropathy
title_short Corneal Confocal Microscopy is Superior to Skin Biopsy as a Surrogate Marker of Human Diabetic Neuropathy
title_sort corneal confocal microscopy is superior to skin biopsy as a surrogate marker of human diabetic neuropathy
topic Confocal microscopy
Corneal nerves
Skin biopsy
Diabetic neuropathy
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/2437.pdf&manuscript_id=2437
work_keys_str_mv AT cquattrini cornealconfocalmicroscopyissuperiortoskinbiopsyasasurrogatemarkerofhumandiabeticneuropathy
AT mtavakoli cornealconfocalmicroscopyissuperiortoskinbiopsyasasurrogatemarkerofhumandiabeticneuropathy
AT pkallinikos cornealconfocalmicroscopyissuperiortoskinbiopsyasasurrogatemarkerofhumandiabeticneuropathy
AT aboulton cornealconfocalmicroscopyissuperiortoskinbiopsyasasurrogatemarkerofhumandiabeticneuropathy
AT nefron cornealconfocalmicroscopyissuperiortoskinbiopsyasasurrogatemarkerofhumandiabeticneuropathy
AT rmalik cornealconfocalmicroscopyissuperiortoskinbiopsyasasurrogatemarkerofhumandiabeticneuropathy